Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
721 0 |
SM ISO690:2012 CROITOR, Lilia, PETRIC, M., SZERB, Elisabeta Ildyko, VLASE, Gabriela, BOUROSH, Pavlina, CHUMAKOV, Yurii, CRIŞAN, Manuela E.. The role of 4-nitrobenzoic acid polymorphs in the crystallization process of organic acid-base multicomponent systems. In: CrystEngComm, 2019, vol. 21, pp. 6038-6047. ISSN 1466-8033. DOI: https://doi.org/10.1039/c9ce01239g |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
CrystEngComm | ||||||
Volumul 21 / 2019 / ISSN 1466-8033 | ||||||
|
||||||
DOI:https://doi.org/10.1039/c9ce01239g | ||||||
Pag. 6038-6047 | ||||||
|
||||||
Rezumat | ||||||
The role of polymorphs in understanding and controlling the crystallization process from solution of an organic acid-base system is reported. Herein, the crystallization process of dimethylethanolammonium 4-nitrobenzoate (DMEA4NB) is explored through different pathways of crystallization, using 4-nitrobenzoic acid polymorphs crystallized in different space groups: Monoclinic P21/n (4NBH) and C2/c (4NBH∗), respectively. The crystal growth process was investigated by complementary experimental techniques such as single crystal and powder X-ray diffraction, Fourier transform infrared spectroscopy, hot-stage optical microscopy and thermogravimetric analysis correlated with an ab initio computational study. The experimental and theoretical data revealed that 4NBH is more stable than 4NBH∗, indicating that 4NBH∗ is more favorable for a one-step crystal growth process, while the 4NBH polymorph leads to DMEA4NB formation through three intermediate phases. The changes over time associated with solid-solid phase transformations in the crystal growth process are evaluated. The opacification process of DMEA4NB has indicated the partially reversible transformation of the product into an intermediate phase. |
||||||
Cuvinte-cheie Crystal growth, Fourier transform infrared spectroscopy, organic acids, single crystals |
||||||
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-86572</cfResPublId> <cfResPublDate>2019-03-13</cfResPublDate> <cfStartPage>6038</cfStartPage> <cfISSN>1466-8033</cfISSN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/86572</cfURI> <cfTitle cfLangCode='EN' cfTrans='o'>The role of 4-nitrobenzoic acid polymorphs in the crystallization process of organic acid-base multicomponent systems</cfTitle> <cfKeyw cfLangCode='EN' cfTrans='o'>Crystal growth; Fourier transform infrared spectroscopy; organic acids; single crystals</cfKeyw> <cfAbstr cfLangCode='EN' cfTrans='o'><p>The role of polymorphs in understanding and controlling the crystallization process from solution of an organic acid-base system is reported. Herein, the crystallization process of dimethylethanolammonium 4-nitrobenzoate (DMEA4NB) is explored through different pathways of crystallization, using 4-nitrobenzoic acid polymorphs crystallized in different space groups: Monoclinic P2<sub>1</sub>/n (4NBH) and C2/c (4NBH∗), respectively. The crystal growth process was investigated by complementary experimental techniques such as single crystal and powder X-ray diffraction, Fourier transform infrared spectroscopy, hot-stage optical microscopy and thermogravimetric analysis correlated with an ab initio computational study. The experimental and theoretical data revealed that 4NBH is more stable than 4NBH∗, indicating that 4NBH∗ is more favorable for a one-step crystal growth process, while the 4NBH polymorph leads to DMEA4NB formation through three intermediate phases. The changes over time associated with solid-solid phase transformations in the crystal growth process are evaluated. The opacification process of DMEA4NB has indicated the partially reversible transformation of the product into an intermediate phase.</p></cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-03-13T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2019-03-13T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-13203</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-03-13T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-61113</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-03-13T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-68562</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-03-13T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-63334</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-03-13T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-197</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-03-13T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-991</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-03-13T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-63332</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-03-13T24:00:00</cfStartDate> </cfPers_ResPubl> <cfFedId> <cfFedIdId>ibn-doi-86572</cfFedIdId> <cfFedId>10.1039/c9ce01239g</cfFedId> <cfStartDate>2019-03-13T24:00:00</cfStartDate> <cfFedId_Class> <cfClassId>31d222b4-11e0-434b-b5ae-088119c51189</cfClassId> <cfClassSchemeId>bccb3266-689d-4740-a039-c96594b4d916</cfClassSchemeId> </cfFedId_Class> <cfFedId_Srv> <cfSrvId>5123451</cfSrvId> <cfClassId>eda2b2e2-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>5a270628-f593-4ff4-a44a-95660c76e182</cfClassSchemeId> </cfFedId_Srv> </cfFedId> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-13203</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-13203-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2019-03-13T24:00:00</cfStartDate> <cfFamilyNames>Croitor</cfFamilyNames> <cfFirstNames>Lilia</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-61113</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-61113-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2019-03-13T24:00:00</cfStartDate> <cfFamilyNames>Petric</cfFamilyNames> <cfFirstNames>M.</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-68562</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-68562-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2019-03-13T24:00:00</cfStartDate> <cfFamilyNames>Szerb</cfFamilyNames> <cfFirstNames>Elisabeta Ildyko</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-63334</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-63334-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2019-03-13T24:00:00</cfStartDate> <cfFamilyNames>Vlase</cfFamilyNames> <cfFirstNames>Gabriela</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-197</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-197-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2019-03-13T24:00:00</cfStartDate> <cfFamilyNames>Bourosh</cfFamilyNames> <cfFirstNames>Pavlina</cfFirstNames> <cfFamilyNames>Боурош</cfFamilyNames> <cfFirstNames>Павлина</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-991</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-991-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2019-03-13T24:00:00</cfStartDate> <cfFamilyNames>Chumakov</cfFamilyNames> <cfFirstNames>Yurii</cfFirstNames> <cfFamilyNames>Чумаков</cfFamilyNames> <cfFirstNames>Юрий</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-63332</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-63332-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2019-03-13T24:00:00</cfStartDate> <cfFamilyNames>Crişan</cfFamilyNames> <cfFirstNames>Manuela E.</cfFirstNames> </cfPersName_Pers> </cfPers> <cfSrv> <cfSrvId>5123451</cfSrvId> <cfName cfLangCode='en' cfTrans='o'>CrossRef DOI prefix service</cfName> <cfDescr cfLangCode='en' cfTrans='o'>The service of issuing DOI prefixes to publishers</cfDescr> <cfKeyw cfLangCode='en' cfTrans='o'>persistent identifier; Digital Object Identifier</cfKeyw> </cfSrv> </CERIF>